AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35068061 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) + tamsulosin
Number of subjects: 63
Study 34691317 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion plus routine drug therapy
Number of subjects: 68
Study 34691317 — intervention group
Group type: COMPARATOR
Intervention: Routine drug therapy (Control)
Number of subjects: 68
Study 98241980 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha) therapy
Number of subjects: 25
Study 98241980 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-treatment liver histology
Number of subjects: 25
Study 98241980 — intervention group
Group type: EXPERIMENTAL
Intervention: Biochemical remission
Number of subjects: 25
Study 34924405 — intervention group
Group type: EXPERIMENTAL
Intervention: 10Hz rTMS at the ipsilesional M1 and 1Hz rTMS at the contralesional M1
Number of subjects: 44
Study 34924405 — intervention group
Group type: COMPARATOR
Intervention: Bilateral sham stimulation at the motor cortices
Number of subjects: 44
Study 36498228 — intervention group
Group type: EXPERIMENTAL
Intervention: 770 mg/day of Tribulus terrestris L. (TT) for 6 weeks
Number of subjects: 30
Study 36498228 — intervention group
Group type: COMPARATOR
Intervention: Placebo daily for 6 weeks
Number of subjects: 30
Study 34469394 — intervention group
Group type: EXPERIMENTAL
Intervention: AutonoMe injector with Clareon IOL
Number of subjects: 30
Study 34469394 — intervention group
Group type: COMPARATOR
Intervention: iSert injector with Vivinex IOL
Number of subjects: 30
Study 34469394 — intervention group
Group type: EXPERIMENTAL
Intervention: Both injectors
Number of subjects: 30
Study 35442404 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 0
Study 35442404 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 35397657 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade fixation
Number of subjects: 30
Study 35397657 — intervention group
Group type: COMPARATOR
Intervention: Retrograde fixation
Number of subjects: 30
Study 34176002 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive interventions (specific interventions not detailed)
Number of subjects: 851
Study 32128909 — intervention group
Group type: EXPERIMENTAL
Intervention: Survivorship planning consultation (SPC)
Number of subjects: 198
Study 32128909 — intervention group
Group type: COMPARATOR
Intervention: Control arm (time-controlled wellness rehabilitation consultation)
Number of subjects: 198
Study 36241249 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive plasma exchange therapy
Number of subjects: 95
Study 36241249 — intervention group
Group type: COMPARATOR
Intervention: Intensive immunosuppressive therapy
Number of subjects: 95
Study 35631229 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (100 mg oral daily for 1 month)
Number of subjects: 0
Study 35631229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34362654 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive technique
Number of subjects: 18
Study 34362654 — intervention group
Group type: COMPARATOR
Intervention: Open surgical technique
Number of subjects: 18
Study 35137108 — intervention group
Group type: EXPERIMENTAL
Intervention: Auricular transcutaneous vagus nerve stimulation (atVNS)
Number of subjects: 45
Study 35137108 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 45
Study 34061402 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceramic implants
Number of subjects: 30
Study 34061402 — intervention group
Group type: COMPARATOR
Intervention: Titanium implants
Number of subjects: 30
Study 34371847 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum HAC01 (n = 20)
Number of subjects: 40
Study 34371847 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 40
Study 32460465 — intervention group
Group type: EXPERIMENTAL
Intervention: Normocarbia (PaCO2: 38‒42 mmHg) for 30 min
Number of subjects: 50
Study 32460465 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypercarbia (PaCO2: 45‒50 mmHg)
Number of subjects: 50
Study 32460465 — intervention group
Group type: COMPARATOR
Intervention: Comparison of normocarbia and hypercarbia
Number of subjects: 50
Study 36301752 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 2-mg
Number of subjects: 0
Study 36301752 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4-mg
Number of subjects: 0
Study 36301752 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33979200 — intervention group
Group type: EXPERIMENTAL
Intervention: VA BIC
Number of subjects: 19
Study 33979200 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 19
Study 32760093 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lidocaine jelly and sub‐Tenon anesthesia with 2 4 ml of 1% ropivacaine
Number of subjects: 54
Study 32760093 — intervention group
Group type: COMPARATOR
Intervention: Peribulbar anesthesia with 4 6 ml of 1% ropivacaine
Number of subjects: 54
Study 34761595 — intervention group
Group type: EXPERIMENTAL
Intervention: 125I radioactive seed implantation combined with EGFR-TKIs
Number of subjects: 108
Study 34761595 — intervention group
Group type: COMPARATOR
Intervention: EGFR-TKIs alone
Number of subjects: 108
Study 35843923 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine 10 mg tablet (test product)
Number of subjects: 24
Study 35843923 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine 10 mg tablet (reference product)
Number of subjects: 24
Study 33465818 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular daily intake of PPIs
Number of subjects: 1298
Study 36153652 — intervention group
Group type: EXPERIMENTAL
Intervention: Third Marriage Checkup (MC)
Number of subjects: 63
Study 36153652 — intervention group
Group type: COMPARATOR
Intervention: Control group (no third MC)
Number of subjects: 63
Study 32898318 — intervention group
Group type: EXPERIMENTAL
Intervention: Single stenting
Number of subjects: 1002
Study 32898318 — intervention group
Group type: COMPARATOR
Intervention: Dual stenting
Number of subjects: 1002
Study 32939553 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A Supplementation (VAS) 50,000 IU
Number of subjects: 306
Study 32939553 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 306
Study 34880668 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate sub‐diaphragmatic irrigation
Number of subjects: 70
Study 34880668 — intervention group
Group type: COMPARATOR
Intervention: Normal saline sub‐diaphragmatic irrigation
Number of subjects: 70
Study 33049114 — intervention group
Group type: EXPERIMENTAL
Intervention: Verubecestat
Number of subjects: 0
Study 33049114 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanabecestat
Number of subjects: 0
Study 33049114 — intervention group
Group type: EXPERIMENTAL
Intervention: Verubecestat and Lanabecestat
Number of subjects: 0
Study 32444867 — intervention group
Group type: EXPERIMENTAL
Intervention: Isatuximab plus pomalidomide and dexamethasone (Isa-Pd)
Number of subjects: 104
Study 32444867 — intervention group
Group type: COMPARATOR
Intervention: Pomalidomide and dexamethasone (Pd)
Number of subjects: 104
Study 32118759 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 100
Study 32118759 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 100
Study 36182782 — intervention group
Group type: EXPERIMENTAL
Intervention: retractor-endoscopic carpal tunnel syndrome (rCTS)
Number of subjects: 80
Study 36182782 — intervention group
Group type: COMPARATOR
Intervention: open carpal tunnel syndrome (oCTS)
Number of subjects: 80
Study 36182782 — intervention group
Group type: EXPERIMENTAL
Intervention: retractor-endoscopic cubital tunnel syndrome (rCbTS)
Number of subjects: 80
Study 36182782 — intervention group
Group type: COMPARATOR
Intervention: open cubital tunnel syndrome (oCbTS)
Number of subjects: 80
Study 34229078 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human albumin (rHA)
Number of subjects: 0
Study 34229078 — intervention group
Group type: COMPARATOR
Intervention: Human serum albumin (HSA)
Number of subjects: 0
Study 32719253 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics group
Number of subjects: 86
Study 32719253 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination group
Number of subjects: 86
Study 32719253 — intervention group
Group type: COMPARATOR
Intervention: Candid group
Number of subjects: 86
Study 33203613 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin
Number of subjects: 1180
Study 33203613 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-histamine
Number of subjects: 1180
Study 33203613 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin
Number of subjects: 1180
Study 33203613 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid pathway related treatment
Number of subjects: 1180
Study 33203613 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron
Number of subjects: 1180
Study 33203613 — intervention group
Group type: COMPARATOR
Intervention: Doxepin
Number of subjects: 1180
Study 32011717 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive extracorporeal circulation (MiECC)
Number of subjects: 60
Study 32011717 — intervention group
Group type: COMPARATOR
Intervention: Conventional extracorporeal circulation
Number of subjects: 60
Study 34448742 — intervention group
Group type: EXPERIMENTAL
Intervention: CXR-positive pneumonia cases
Number of subjects: 630
Study 34448742 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory syncytial virus
Number of subjects: 630
Study 34448742 — intervention group
Group type: EXPERIMENTAL
Intervention: S. pneumoniae
Number of subjects: 630
Study 34448742 — intervention group
Group type: EXPERIMENTAL
Intervention: H. influenza
Number of subjects: 630
Study 34448742 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalized cases
Number of subjects: 630
Study 32106812 — intervention group
Group type: EXPERIMENTAL
Intervention: PECS + ESP
Number of subjects: 30
Study 32106812 — intervention group
Group type: COMPARATOR
Intervention: ESP
Number of subjects: 30
Study 35597794 — intervention group
Group type: EXPERIMENTAL
Intervention: Phaco-canaloplasty (PC)
Number of subjects: 75
Study 35597794 — intervention group
Group type: COMPARATOR
Intervention: Phaco-non-penetrating deep sclerectomy (PDS)
Number of subjects: 75
Study 34764311 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured exercise (3-day program with initial education and three daily active exercise sessions)
Number of subjects: 61
Study 34764311 — intervention group
Group type: COMPARATOR
Intervention: Control group (no structured exercise)
Number of subjects: 61
Study 32352714 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label rifaximin 550 mg 3 times daily for 2 weeks
Number of subjects: 2438
Study 32352714 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind rifaximin 550 mg 3 times daily
Number of subjects: 2438
Study 33787561 — intervention group
Group type: EXPERIMENTAL
Intervention: PFMT using the motion-based digital therapeutic device
Number of subjects: 61
Study 33787561 — intervention group
Group type: COMPARATOR
Intervention: PFMT alone (control group)
Number of subjects: 61
Study 33979219 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency contact ultrasonic debridement therapy (LFCUD) with polyhexamethylene biguanide (PHMB)
Number of subjects: 50
Study 33979219 — intervention group
Group type: COMPARATOR
Intervention: Low-frequency contact ultrasonic debridement therapy (LFCUD) alone
Number of subjects: 50
Study 36368336 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month oral regimen with bedaquiline
Number of subjects: 588
Study 36368336 — intervention group
Group type: COMPARATOR
Intervention: 9-month control regimen
Number of subjects: 588
Study 36368336 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month regimen with bedaquiline and 8 weeks of second-line injectable
Number of subjects: 588
Study 35247743 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-pleural immunotherapy (part of the TILT trial)
Number of subjects: 12
Study 32075674 — intervention group
Group type: COMPARATOR
Intervention: Combined interscalene brachial plexus with superficial cervical plexus block (IC)
Number of subjects: 80
Study 32075674 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined thoracic paravertebral block with brachial plexus and superficial cervical plexus block (ICTP)
Number of subjects: 80
Study 35761317 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive intervention arm
Number of subjects: 34
Study 35761317 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention
Number of subjects: 34
Study 34507019 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) program for 8 weeks
Number of subjects: 63
Study 33940595 — intervention group
Group type: EXPERIMENTAL
Intervention: High threat × Loss frame article
Number of subjects: 1350
Study 33940595 — intervention group
Group type: EXPERIMENTAL
Intervention: High threat × Gain frame article
Number of subjects: 1350
Study 33267966 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive attitudes
Number of subjects: 5213
Study 33267966 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative attitudes
Number of subjects: 5213
Study 33267966 — intervention group
Group type: COMPARATOR
Intervention: Abstainers/low users (ABS)
Number of subjects: 5213
Study 34056987 — intervention group
Group type: EXPERIMENTAL
Intervention: Information‐Motivation and Behavioral skills (IMB) model‐based counseling for four sessions (n = 70)
Number of subjects: 137
Study 34056987 — intervention group
Group type: COMPARATOR
Intervention: Antenatal usual care (AUC) (n = 67)
Number of subjects: 137
Study 34056987 — intervention group
Group type: EXPERIMENTAL
Intervention: Information‐Motivation and Behavioral skills (IMB) model‐based counseling
Number of subjects: 137
Study 33920623 — intervention group
Group type: EXPERIMENTAL
Intervention: Strained tomato purée
Number of subjects: 0
Study 33920623 — intervention group
Group type: EXPERIMENTAL
Intervention: Rustic tomato purée
Number of subjects: 0
Study 33028277 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 272
Study 33028277 — intervention group
Group type: EXPERIMENTAL
Intervention: Holding back urine
Number of subjects: 272
Study 33028277 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety or irritability
Number of subjects: 272
Study 33028277 — intervention group
Group type: EXPERIMENTAL
Intervention: Contraception
Number of subjects: 272
Study 33028277 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking status
Number of subjects: 272
Study 36048797 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking impairment (measured by Walking Impairment Questionnaire)
Number of subjects: 1696
Study 36048797 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking impairment
Number of subjects: 1696
Study 36048797 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 1696
Study 34928477 — intervention group
Group type: EXPERIMENTAL
Intervention: rhBMP-2/β-TCP (n = 41, test group)
Number of subjects: 84
Study 34928477 — intervention group
Group type: COMPARATOR
Intervention: β-TCP (n = 43, control group)
Number of subjects: 84
Study 34928477 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 84
Study 34987288 — intervention group
Group type: EXPERIMENTAL
Intervention: CSM-PLT
Number of subjects: 402
Study 34987288 — intervention group
Group type: COMPARATOR
Intervention: Conventional ESD
Number of subjects: 402
Study 33164915 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal night of sleep
Number of subjects: 16
Study 33164915 — intervention group
Group type: EXPERIMENTAL
Intervention: Total sleep deprivation (30 h)
Number of subjects: 16
Study 616576545 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin + sitagliptin (100 mg once daily)
Number of subjects: 50
Study 616576545 — intervention group
Group type: COMPARATOR
Intervention: Insulin
Number of subjects: 50
Study 35556087 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical vignettes and problem-based learning (PBL) combined with prosected cadavers
Number of subjects: 137
Study 32102679 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic treatment combined with moving cupping therapy
Number of subjects: 122
Study 32102679 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment combined with moving cupping placebo
Number of subjects: 122
Study 36190113 — intervention group
Group type: EXPERIMENTAL
Intervention: LIPA
Number of subjects: 28
Study 36190113 — intervention group
Group type: EXPERIMENTAL
Intervention: EX
Number of subjects: 28
Study 35446735 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day mobile-based educational intervention
Number of subjects: 509
Study 35446735 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 509
Study 33752447 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel Intubating Laryngeal Mask Airway (ILMA)
Number of subjects: 200
Study 33752447 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Tube (ETT)
Number of subjects: 200
Study 32925978 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban locations
Number of subjects: 1283
Study 32925978 — intervention group
Group type: COMPARATOR
Intervention: Rural locations
Number of subjects: 1283
Study 32925978 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 1283
Study 32925978 — intervention group
Group type: EXPERIMENTAL
Intervention: Susceptible individuals in urban areas
Number of subjects: 1283
Study 32925978 — intervention group
Group type: EXPERIMENTAL
Intervention: Urban participants with prior history of dengue
Number of subjects: 1283
Study 32925978 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural participants who traveled outside their vereda
Number of subjects: 1283
Study 32925978 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural participants born outside of Santander department
Number of subjects: 1283
Study 35565077 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical debridement therapy assisted using Bioptron Hyperlight Therapy
Number of subjects: 40
Study 35565077 — intervention group
Group type: COMPARATOR
Intervention: Mechanical debridement therapy alone
Number of subjects: 40
Study 34971065 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-structured conversations (video chats) with interviewers four times per week for up to one year.
Number of subjects: 39
Study 35906929 — intervention group
Group type: EXPERIMENTAL
Intervention: Featback, a fully automated online self‐help intervention
Number of subjects: 355
Study 35906929 — intervention group
Group type: EXPERIMENTAL
Intervention: Chat or email support from a recovered expert patient
Number of subjects: 355
Study 35906929 — intervention group
Group type: EXPERIMENTAL
Intervention: Featback with expert‐patient support
Number of subjects: 355
Study 35906929 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition
Number of subjects: 355
Study 32595055 — intervention group
Group type: EXPERIMENTAL
Intervention: IV Lidocaine (5 cc = 100 mg)
Number of subjects: 104
Study 32595055 — intervention group
Group type: COMPARATOR
Intervention: IV Morphine sulfate (5 cc = 5 mg)
Number of subjects: 104
Study 36380383 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported adherence
Number of subjects: 233
Study 36380383 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy refill count
Number of subjects: 233
Study 36380383 — intervention group
Group type: EXPERIMENTAL
Intervention: Real Time Medication Monitoring (RTMM)
Number of subjects: 233
Study 36380383 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of self-report and pharmacy refill count
Number of subjects: 233
Study 36380383 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of all three measures (self-report, pharmacy refill count, RTMM)
Number of subjects: 233
Study 32243365 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal transcranial direct current stimulation (tDCS) over the contralesional premotor area with robotic arm rehabilitation, 10 sessions, 25 minutes each.
Number of subjects: 36
Study 32243365 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS during robotic arm rehabilitation, 10 sessions, 25 minutes each.
Number of subjects: 36
Study 32243365 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS with robotic arm rehabilitation
Number of subjects: 36
Study 32243365 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS with robotic arm rehabilitation
Number of subjects: 36
Study 35655850 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine group (DG)
Number of subjects: 80
Study 35655850 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 80
Study 32567217 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment A (3 mg/mL)
Number of subjects: 24
Study 32567217 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment B (1 mg/mL)
Number of subjects: 24
Study 36184889 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 0
Study 36184889 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33337391 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.75 mg/kg/day for 6 days)
Number of subjects: 1
Study 33337391 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone discontinued after 6 days
Number of subjects: 1
Study 34904270 — intervention group
Group type: EXPERIMENTAL
Intervention: Linzagolix 25–200 mg daily
Number of subjects: 0
Study 34904270 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35853037 — intervention group
Group type: EXPERIMENTAL
Intervention: Asynchronous telerehabilitation group
Number of subjects: 50
Study 35853037 — intervention group
Group type: COMPARATOR
Intervention: Booklet-based rehabilitation group
Number of subjects: 50
Study 32792163 — intervention group
Group type: EXPERIMENTAL
Intervention: Open transumbilical intussusception reduction (OTIR), n = 27
Number of subjects: 51
Study 32792163 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic reduction (LAP), n = 24
Number of subjects: 51
Study 34126560 — intervention group
Group type: EXPERIMENTAL
Intervention: UDTM control and FES
Number of subjects: 16
Study 34126560 — intervention group
Group type: COMPARATOR
Intervention: FSTM control only
Number of subjects: 16
Study 34126560 — intervention group
Group type: EXPERIMENTAL
Intervention: FES with FSTM control
Number of subjects: 16
Study 34126560 — intervention group
Group type: EXPERIMENTAL
Intervention: UDTM control only
Number of subjects: 16